Abstract:Aim: The idea that intravenous lipid emulsion (ILE) may serve as a "reservoir" for lipophilic drugs has emerged in research as an intravascular "lipid sink" effect. Carbamazepine (CBZ) is a widely used anticonvulsant. This compound has a neutral and highly lipophilic structure and can easily cross body membranes. In this study, our hypothesis focused on the potential efficacy of ILE in modulating blood carbamazepine concentrations. Material and Methods: 22 adult Sprague-Dawley rats were divided into four groups. All groups received CBZ at a dose of 20 mg/kg orogastrically. The first group was the control group. In the second group (activated charcoal group), activated charcoal (AC) was administered orogastrically at a dose of 1 g/kg five minutes after orogastric administration of carbamazepine. The third group (lipid group) received ILE at a dose of 3 ml/kg/min at the fifth minute. The fourth group was the saline group, in which 16 ml/kg of 0.9% NaCl was infused at the fifth minute. Blood samples of 0.5 ml were collected at 0, 4, 8, and 24 hours. Plasma was separated by centrifugation (4000 rpm, 10 minutes) and stored at -80oC for determination of CBZ concentrations. An Agilent 6410B HP-1200 LC series (USA) liquid chromatography system was used for analysis. Quantitative analysis was performed in the multiple reaction mode with electrospray positive ionization (ES+). Results: At the 8th hour of orogastric CBZ administration, CBZ concentration was significantly lower in the activated charcoal group than in the lipid and saline groups (p: 0.021; p: 0.023; p0.05). In the lipid group, the increase in CBZ plasma concentrations was statistically significant at 4 and 8 hours compared to 0 hours (p: 0.005; p: 0.005, respectively). Conclusion: In the lipid group, plasma CBZ concentrations increased at 4 and 8 hours in plasma samples from which lipids were separated by differential centrifugation. In the lipid group, no effects favoring drug-lipid sequestration on the plasma distribution of CBZ were observed.

Relative Bioavailability of Different Carbamazepine Tablets in Rabbits

A Comparative Bioavailability Study of Carbamazepine Tablets and a Chewable Tablet Formulation

Study on bioequivalence of cilostazol table in healthy volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Absolute Bioavailability of Breviscapine Sustained Release Tablet in Rabbit

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

The Effect of Carbamazepine on Performance, Carcass Value, Hematological and Biochemical Blood Parameters, and Detection of Carbamazepine and Its Metabolites in Tissues, Internal Organs, and Body Fluids in Growing Rabbits

Relative bioavailability of cefpodoxime proxetil tablets in healthy volunteers

Comparison of Pharmacokinetics of 10-Hydroxycamptothecin Between Nebulized Inhalation and Intravenous Administration in Rabbits

Evaluation of Lipid Emulsion-Mediated Sequestration and Redistribution of the Highly Lipophilic Carbamazepine in the Plasma of Rats

Study on Pharmacokinetics and Bioavailability of Potassium Dehydroandrographolide Succinate Hollow Suppositories in Rabbits

Bioavailability of Bicalutamide Tablets in Beagle Dogs

Pharmacokinetics of Diammonium Glycyrrhizinate Effervescent Granules in Rabbits

Study on Relative Bioavailability of Two Flunarizine Hydrochloride Capsules

The relative bioavailability of allopurinol tablets in man

Study on Bioequivalence of Risperidone Tablets

Plasma concentration of sibutramine hydrochloride in beagle dog assayed by LC-MS and study on its pharmacokinetics

Studies on the pharmacokinetic-pharmacodynamic model of ketoprofen beta-CD inclusion complex in rabbits]

Bioequivalence of Levodopa and Benserazide Hydrochloride Capsules in Beagle Dogs